LexDanaLexDanabeta
Inventor

DEEPAK SAMPATH

Inventor
US

Overview

2→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
11,590,128Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor202311,413,282Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to ABBVIE INC (2)· patent assignee history
2022–2023Patents assigned to GENENTECH INC (2)· patent assignee history
2022–2023Patents assigned to HOFFMANN LA ROCHE (2)· patent assignee history
2022–2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ABBVIE INC22022–2023
GENENTECH INC22022–2023
HOFFMANN LA ROCHE22022–2023
Locations
LocationPatentsSpan
US22022–2023